270 related articles for article (PubMed ID: 20166862)
1. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.
Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP
Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.
Cevik MA; Erbay A; Bodur H; Gülderen E; Baştuğ A; Kubar A; Akinci E
Int J Infect Dis; 2008 Jul; 12(4):374-9. PubMed ID: 18063402
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.
Ergonul O; Celikbas A; Baykam N; Eren S; Dokuzoguz B
Clin Microbiol Infect; 2006 Jun; 12(6):551-4. PubMed ID: 16700704
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions.
Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H
Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082
[TBL] [Abstract][Full Text] [Related]
5. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.
Tasdelen Fisgin N; Tanyel E; Doganci L; Tulek N
Trop Doct; 2009 Jul; 39(3):158-60. PubMed ID: 19535753
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.
Hekimoğlu HC; Demirci NA
Afr Health Sci; 2014 Dec; 14(4):873-81. PubMed ID: 25834496
[TBL] [Abstract][Full Text] [Related]
8. Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.
Ekiz F; Gürbüz Y; Basar Ö; Aytekin G; Ekiz Ö; Sentürk ÇŞ; Aktas B; Yılmaz B; Altınbaş A; Çoban Ş; Şencan İ
Clin Appl Thromb Hemost; 2013; 19(4):441-4. PubMed ID: 22431857
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
Duygu F; Kaya T; Baysan P
Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
[TBL] [Abstract][Full Text] [Related]
10. Crimean-Congo hemorrhagic fever in Turkey.
Karti SS; Odabasi Z; Korten V; Yilmaz M; Sonmez M; Caylan R; Akdogan E; Eren N; Koksal I; Ovali E; Erickson BR; Vincent MJ; Nichol ST; Comer JA; Rollin PE; Ksiazek TG
Emerg Infect Dis; 2004 Aug; 10(8):1379-84. PubMed ID: 15496237
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
Uyar Y; Carhan A; Albayrak N; Altaş AB
Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
[TBL] [Abstract][Full Text] [Related]
12. Crimean-Congo hemorrhagic fever disease due to tick bite with very long incubation periods.
Kaya A; Engin A; Güven AS; Içağasıoğlu FD; Cevit O; Elaldı N; Gültürk A
Int J Infect Dis; 2011 Jul; 15(7):e449-52. PubMed ID: 21511509
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever.
Gürbüz E; Ekici A; Ünlü AH; Yılmaz H
Turk J Med Sci; 2021 Aug; 51(4):1825-1832. PubMed ID: 33754650
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
[TBL] [Abstract][Full Text] [Related]
15. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.
Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F
J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724
[TBL] [Abstract][Full Text] [Related]
17. Imported Crimean-Congo hemorrhagic fever cases in Istanbul.
Midilli K; Gargili A; Ergonul O; Sengöz G; Ozturk R; Bakar M; Jongejan F
BMC Infect Dis; 2007 Jun; 7():54. PubMed ID: 17553137
[TBL] [Abstract][Full Text] [Related]
18. A newly identified Crimean-Congo hemorrhagic fever virus strain in Turkey.
Elevli M; Ozkul AA; Civilibal M; Midilli K; Gargili A; Duru NS
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e213-6. PubMed ID: 20005760
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever.
Yilmaz M; Aydin K; Akdogan E; Sucu N; Sonmez M; Omay SB; Koksal I
J Clin Virol; 2008 Aug; 42(4):415-7. PubMed ID: 18434247
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
